TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: treatment outcome for bCBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: presence of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duodenal eosinophil count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean primary stent patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median survival since the insertion of the stent
Endpoint domain: Mortality/survival
Primary endpoint: Neurodevelopmental outcomes at 36 months
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Median number of potential adverse events (AEs) per patient
Endpoint domain: Adverse events/effects
Primary endpoint: Number of nausea and vomiting episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: self-reported distracted driving behaviors
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: hot flushes severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral patellar displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Death or subsequent Type 1 or 4b myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: pSUVmax as a predictor for pPDL1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in nighttime urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in urinary urgency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in urgency incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Internalization score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Externalization score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in response accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MIP/MEP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of alcoholic drinks consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence (AUC96‐264)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence (Cmax96‐264)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence (Cmin96‐264)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of overall FBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year cumulative death and disease progression
Endpoint domain: Mortality/survival
Primary endpoint: 5-year cumulative incidence recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Patient‐Rated Tennis Elbow Evaluation Scale (PRTEE) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in Skindex‐29 symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional Assessment of Cancer Therapy‐General physical well‐being
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mucosal impedance recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability outcome at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage change from baseline to 24 months in mean IMT of the CCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: average treatment time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anal function protection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of microbial keratitis (MK)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of non-infectious inflammatory adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: remineralization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Development of severe OHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine attacks developed after VIP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of headache intensity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of superficial temporal artery diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in unnecessary hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improved clinician confidence in management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved understanding of bronchiolitis management
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pain-related outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POSAS score after 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 8-km foot march performance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health status index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in EQ-VAS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in presenting red flag
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High depression symptom severity associated with HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence rate to training protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CUEQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain perception during injection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eczema Area and Severity Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient‐Oriented Eczema Measure score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total number of additional steroid ointment applications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: EDN concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak VO2 decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: muscle loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KSS-K and KSS-F scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HKA, MPTA, and PCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle cell damage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of 25(OH)D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SNOT-22 symptoms scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of HIV tests taken by MSM participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propofol consumption per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cough and body movement
Endpoint domain: Adverse events/effects
Primary endpoint: AF recurrence ≥30 s
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: weight growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coagulation function 90 min after separating from CPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUC (areas under ROC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete or partial response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean stone fragmentation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean total operation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean change in e' velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Attitudes towards older adult care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative incidence of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Preference for fear appeal message
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Night-time acid suppression (% time at pH ≥ 4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of Hospital Stay (LOH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Navicular drop test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Star Excursion Balance Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic knee valgus during single-leg squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superficial surgical site infections (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: surgical site complications (SSCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Evidence-based smoking cessation treatment provision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of OMERACT-OARSI responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid medication disposal rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: balance and walking improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum follistatin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body fat percentage (BFP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Aura symptoms induced
Endpoint domain: Adverse events/effects
Primary endpoint: Headache development
Endpoint domain: Adverse events/effects
Primary endpoint: Migraine-like attacks
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed malaria cases
Endpoint domain: Mortality/survival
Primary endpoint: WSRS response rates at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Aesthetic Improvement Scale (GAIS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IgG GMC at primary immunological endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: motor dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average decrease in VAS pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Application time of iTClamp vs pressure dressings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported oral health status (OHS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MHRQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in area under the curve of the arteriole response to flickering light
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in other tobacco/nicotine use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in marijuana use frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of nausea vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS of nausea degree at 24 h after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS of nausea degree at 24 to 48 h after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone defect area healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of chronic osteomyelitis
Endpoint domain: Adverse events/effects
Primary endpoint: ERG amplitude reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remineralization of white spot lesions (WSLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of smoked cigarettes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time sensor glucose in the target range (3.9–10.0 mmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: per-protocol R0 resection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: per-protocol N0 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ITT N0 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: RAO 1-h post TR-band removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Expiratory tidal volume (TVe) of 4-8 ml/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: language scales scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of the intervention group compared to control group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: global functional limitation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum GDF-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Control Test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported dental pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean half-life of ASP0367
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upregulation of PPARδ target genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of Enterobacteriaceae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of Bacteroides
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of Prevotella
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous clearance of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Finger-to-floor (FTF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater reliability of dynamic muscle tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: moral sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self‐rated goal attainment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Learning rates from punishment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality adjusted life years gain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean size of the largest wart
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean onset of first response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACh-induced vasoconstrictive responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mental Health Knowledge Schedule
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Irritation Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Internal consistency of STAI-Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Convergent validity between STAI-Y and BAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of lung cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in activities of daily living of upper limb
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean score of stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESM adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attenuation of pneumonia lesions on chest CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6‐min walk distance (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue Assessment Inventory (FAI) scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Segmental hypoalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extrasegmental hypoalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: 10% increase in VO2peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exercise-induced fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: area under the curve (AUC0‐24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of patient's well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevention of fatal and nonfatal events
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of ALRTI
Endpoint domain: Adverse events/effects
Primary endpoint: Cost of infection-associated medical expenditure
Endpoint domain: Resource use
Primary endpoint: Fondness for HIIE over MICE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for HIIE over MICE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of excellent responses to the Pediatric Family Satisfaction in the ICU 24 decision‐making domain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean CAPS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: movement smoothness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cormack‐Lehane grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of difficult laryngoscopies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean intraoperative sufentanil dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular cement leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Extension of uterine incision
Endpoint domain: Adverse events/effects
Primary endpoint: Need for repeat infusion
Endpoint domain: Adverse events/effects
Primary endpoint: mechanical pain thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative hyperalgesia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body weight average reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin resistance (IR) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Depression level reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotional comfort levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical comfort levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physical demand on nurses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of initiating antihypertensive therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of therapy escalation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hunger and desire to eat
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vascular index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol concentrations at individual time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUC0-24h within the 90% reference range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean number of births
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes